Vyome Holdings (HIND) Other Non Operating Income (2015 - 2026)
Vyome Holdings (HIND) posted quarterly Other Non Operating Income of $147264.0 for Q1 2026, up 3768.76% year-over-year from $3806.5 in Q1 2025, and up 72.57% quarter-over-quarter from $85338.0 in Q4 2025.
Vyome Holdings (HIND) Other Non Operating Income (2015 - 2026) Analysis & Trends
Vyome Holdings' Other Non Operating Income history runs 12 years deep, the most recent figure standing at $147264.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 3768.76% year-over-year to $147264.0; the TTM figure through Mar 2026 stood at $297216.0 (down 30.41% YoY), while the FY2025 annual figure was $90987.0, up 2285.61% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $147264.0, up from $85338.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $478000.0 in Q4 2022, with the low at -$279000.0 in Q3 2022.
- The 5-year median for Other Non Operating Income is $6000.0 (2023), against an average of $45253.5.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income tumbled 376.24% in 2022, then surged 7050.0% in 2024.
- Vyome Holdings' Other Non Operating Income stood at $478000.0 in 2022, then sank by 85.56% to $69000.0 in 2023, then tumbled by 97.87% to $1469.0 in 2024, then jumped by 5709.26% to $85338.0 in 2025, then jumped by 72.57% to $147264.0 in 2026.
- Business Quant data shows HIND's Other Non Operating Income at $147264.0 in Q1 2026, $85338.0 in Q4 2025, and $4614.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Vyome Holdings | 16.07 Mn | 8.18 Mn | 11,658.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 146,208.00 |
| Mar 31, 2026 | 147,264.00 |
| Dec 31, 2025 | 85,338.00 |
| Sep 30, 2025 | 4,614.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | -4,014.00 |
| Dec 31, 2024 | 1,469.00 |
| Sep 30, 2024 | 638.00 |
| Jun 30, 2024 | 429,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | 69,000.00 |
| Sep 30, 2023 | -68,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2022 | 478,000.00 |
| Sep 30, 2022 | -279,000.00 |
| Jun 30, 2022 | -204,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Sep 30, 2021 | 101,000.00 |
| Jun 30, 2021 | -101,000.00 |